Carsten Marr
Carsten Marr is using machine learning to advance research, diagnosis, and treatment of serious blood disorders.
AI in healthcare
Single-cell analysis
Blood diseases
Carsten Marr is the founding director of the Institute for AI in Healthcare at Helmholtz Munich, a European center for applied artificial intelligence. Marr is considered a pioneer in AI-supported diagnostics and therapy, especially for serious blood disorders. His models for predicting stem cell decisions and for automatic leukemia detection in blood smears are groundbreaking.
With his interdisciplinary team, Marr develops customized algorithms for analyzing single-cell-resolution data, which is often a prerequisite for individually tailored therapies.
Marr has received numerous awards for his research, including an ERC Consolidator Grant and the Eugen Münch Prize for innovative healthcare. He studied physics at the Technical University of Munich and the Max Planck Institute for Quantum Optics, then switched to biology and earned his doctorate at the Technical University of Darmstadt. He has been conducting research at Helmholtz Munich since 2013. Since 2025, he has also been Professor of AI in Hematology and Cell Therapy at LMU Munich.
